- Keeler, G. D., Kumar, S., Palaschak, B., Silverberg, E. L., Markusic, D. M., Jones, N. T., & Hoffman, B. E. (2018). Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple Sclerosis. Molecular therapy : the journal of the American Society of Gene Therapy, 26(1), 173–183.
- Herzog, R. W., Cooper, M., Perrin, G. Q., Biswas, M., Martino, A. T., Morel, L., Terhorst, C., & Hoffman, B. E. (2019). Regulatory T cells and TLR9 activation shape antibody formation to a secreted transgene product in AAV muscle gene transfer. Cellular immunology, 342, 103682.
- Rogers, G. L., Shirley, J. L., Zolotukhin, I., Kumar, S., Sherman, A., Perrin, G. Q., Hoffman, B. E., Srivastava, A., Basner-Tschakarjan, E., Wallet, M. A., Terhorst, C., Biswas, M., & Herzog, R. W. (2017). Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells. Blood, 129(24), 3184–3195.
- Krotova, K., Marek, G. W., Wang, R. L., Aslanidi, G., Hoffman, B. E., Khodayari, N., Rouhani, F. N., & Brantly, M. L. (2017). Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity. American journal of respiratory cell and molecular biology, 57(2), 238–247.
- Kumar, S., Hoffman, B. E., Terhorst, C., de Jong, Y. P., & Herzog, R. W. (2017). The Balance between CD8+ T Cell-Mediated Clearance of AAV-Encoded Antigen in the Liver and Tolerance Is Dependent on the Vector Dose. Molecular therapy : the journal of the American Society of Gene Therapy, 25(4), 880–891.
- Zolotukhin, I., Markusic, D. M., Palaschak, B., Hoffman, B. E., Srikanthan, M. A., & Herzog, R. W. (2016). Potential for cellular stress response to hepatic factor VIII expression from AAV vector. Molecular therapy. Methods & clinical development, 3, 16063.
- Vercauteren, K., Hoffman, B. E., Zolotukhin, I., Keeler, G. D., Xiao, J. W., Basner-Tschakarjan, E., High, K. A., Ertl, H. C., Rice, C. M., Srivastava, A., de Jong, Y. P., & Herzog, R. W. (2016). Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid. Molecular therapy : the journal of the American Society of Gene Therapy, 24(6), 1042–1049.
- Campbell, S. A., & Hoffman, B. G. (2016). Chromatin Regulators in Pancreas Development and Diabetes. Trends in endocrinology and metabolism: TEM, 27(3), 142–152.
- Xiao, Y., Kwon, K. C., Hoffman, B. E., Kamesh, A., Jones, N. T., Herzog, R. W., & Daniell, H. (2016). Low cost delivery of proteins bioencapsulated in plant cells to human non-immune or immune modulatory cells. Biomaterials, 80, 68–79.
- Tennant, B. R., Hurley, P., Dhillon, J., Gill, A., Whiting, C., & Hoffman, B. G. (2015). The TrxG Complex Mediates Cytokine Induced De Novo Enhancer Formation in Islets. PloS one, 10(10), e0141470.
- Pandya, M., Britt, K., Hoffman, B., Ling, C., & Aslanidi, G. V. (2015). Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer. Journal of immunotherapy (Hagerstown, Md. : 1997), 38(7), 292–298.
- Tennant, B. R., Chen, J., Shih, A. Z., Luciani, D. S., & Hoffman, B. G. (2015). Myt3 Mediates Laminin-V/Integrin-β1-Induced Islet-Cell Migration via Tgfbi. Molecular endocrinology (Baltimore, Md.), 29(9), 1254–1268.
- Wang, X., Su, J., Sherman, A., Rogers, G. L., Liao, G., Hoffman, B. E., Leong, K. W., Terhorst, C., Daniell, H., & Herzog, R. W. (2015). Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cells. Blood, 125(15), 2418–2427.
- Sarkar, D., Biswas, M., Liao, G., Seay, H. R., Perrin, G. Q., Markusic, D. M., Hoffman, B. E., Brusko, T. M., Terhorst, C., & Herzog, R. W. (2014). Ex Vivo Expanded Autologous Polyclonal Regulatory T Cells Suppress Inhibitor Formation in Hemophilia. Molecular therapy. Methods & clinical development, 1, 14030–.
- Markusic, D. M., Hoffman, B. E., Perrin, G. Q., Nayak, S., Wang, X., LoDuca, P. A., High, K. A., & Herzog, R. W. (2013). Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies. EMBO molecular medicine, 5(11), 1698–1709.
- Hoffman, B. E., & Herzog, R. W. (2013). Covert warfare against the immune system: decoy capsids, stealth genomes, and suppressors. Molecular therapy : the journal of the American Society of Gene Therapy, 21(9), 1648–1650.
- Rogers, G. L., & Hoffman, B. E. (2012). Optimal Immunofluorescent Staining for Human Factor IX and Infiltrating T Cells following Gene Therapy for Hemophilia B. Journal of genetic syndromes & gene therapy, S1, 012.
- Tennant, B. R., Islam, R., Kramer, M. M., Merkulova, Y., Kiang, R. L., Whiting, C. J., & Hoffman, B. G. (2012). The transcription factor Myt3 acts as a pro-survival factor in β-cells. PloS one, 7(12), e51501.
- Hoffman, B. E., Ertl, H. C., Terhorst, C., High, K. A., & Herzog, R. W. (2012). Gene therapy research at the frontiers of viral immunology. Frontiers in microbiology, 3, 182.
- Szabat, M., Lynn, F. C., Hoffman, B. G., Kieffer, T. J., Allan, D. W., & Johnson, J. D. (2012). Maintenance of β-cell maturity and plasticity in the adult pancreas: developmental biology concepts in adult physiology. Diabetes, 61(6), 1365–1371.